NCT00532012View on ClinicalTrials.gov

Phase-I Study Evaluating the Pharmacokinetic Profile of RhuDex®

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

October 31, 2007

Study Completion Date

November 30, 2007

Conditions
Pharmacokinetics
Interventions
DRUG

RhuDex®

Trial Locations (1)

EH14 4AP

Charles River Clinical Services Edinburgh Ltd, Edinburgh

Sponsors

Lead Sponsor

MediGene
All Listed Sponsors
lead

MediGene

INDUSTRY

NCT00532012 - Phase-I Study Evaluating the Pharmacokinetic Profile of RhuDex® | Biotech Hunter | Biotech Hunter